33484 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on 

whether the proposed transaction 

complies with the standards 

enumerated in the HOLA (12 U.S.C. 

1467a(e)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than June 30, 2022. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Fidelity Federal Bancorp, 

Evansville, Indiana, and its parent 

companies, Pedcor Financial, LLC and 

Pedcor Financial Bancorp, both of 

Carmel, Indiana; to become savings and 

loan holding companies, following their 

conversion to bank holding companies 

for a moment in time in connection with 

the acquisition of Community Banks of 

Shelby County, Cowden, Illinois. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–11778 Filed 6–1–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services. 

ACTION: Notice of public meeting. 

SUMMARY: This notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality. 

DATES: The meeting will be held on 

Thursday, July 21, 2022, from 12:30 

p.m. to 4:30 p.m. 

ADDRESSES: The meeting will be held 

virtually for the public. Members of the 

National Advisory Council will be able 

to participate in-person or virtually. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Mail Stop 06E37A, 

Rockville, Maryland, 20857, (301) 427– 

1456. For press-related information, 

please contact Bruce Seeman at (301) 

427–1998 or Bruce.Seeman@

AHRQ.hhs.gov. 

Closed captioning will be provided 

during the meeting. If another 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than 

Monday, May 2, 2022. The agenda, 

roster, and minutes will be available 

from Ms. Heather Phelps, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Rockville, Maryland, 

20857. Ms. Phelps’ phone number is 

(301) 427–1128. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

In accordance with section 10(a) of 

the Federal Advisory Committee Act, 5 

U.S.C. App., this notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality (the Council). The Council is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director of AHRQ on 

matters related to AHRQ’s conduct of its 

mission including providing guidance 

on (A) priorities for health care research, 

(B) the field of health care research 

including training needs and 

information dissemination on health 

care quality and (C) the role of the 

Agency in light of private sector activity 

and opportunities for public private 

partnerships. The Council is composed 

of members of the public, appointed by 

the Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Thursday, July 21, 2022, NAC 

members will meet to conduct 

preparatory work prior to convening the 

Council meeting at 12:30 p.m., with the 

call to order by the Council Chair and 

approval of previous Council summary 

notes. The meeting will begin with an 

introduction of NAC members and a 

report by the AHRQ Director. The NAC 

will then commence a discussion of the 

meaning of quality across healthcare 

delivery systems in the future and the 

impact of innovations in the healthcare 

marketplace. The meeting is open to the 

public and will adjourn at 4:30 p.m. For 

information regarding how to access the 

meeting as well as other meeting details, 

including information on how to make 

a public comment, please go to https:// 

www.ahrq.gov/news/events/nac/. The 

final agenda will be available on the 

AHRQ Website no later than Thursday, 

July 7, 2022. 

Dated: May 26, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–11807 Filed 6–1–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–0728] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Notifiable Diseases Surveillance System 

(NNDSS)’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on February 

14, 2022 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33485 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

National Notifiable Diseases 

Surveillance System (NNDSS) (OMB 

Control No. 0920–0728, Exp. 3/31/ 

2024)—Revision—Center for 

Surveillance, Epidemiology and 

Laboratory Services (CSELS), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Public Health Services Act (42 

U.S.C. 241) authorizes CDC to 

disseminate nationally notifiable 

condition information. The National 

Notifiable Diseases Surveillance System 

(NNDSS) is based on data collected at 

the state, territorial and local levels as 

a result of legislation and regulations in 

those jurisdictions that require health 

care providers, medical laboratories, 

and other entities to submit healthrelated data on reportable conditions to 

public health departments. These 

reportable conditions, which include 

infectious and non-infectious diseases, 

vary by jurisdiction depending upon 

each jurisdiction’s health priorities and 

needs. Each year, the Council of State 

and Territorial Epidemiologists (CSTE), 

supported by CDC, determines which 

reportable conditions should be 

designated nationally notifiable or 

under standardized surveillance. 

CDC requests a three-year approval for 

a Revision for the NNDSS (OMB Control 

No. 0920–0728, Exp. 3/31/2024). This 

Revision includes requests for approval 

to: (1) Receive case notification data for 

Alpha-gal syndrome (AGS), a new 

condition under standardized 

surveillance (CSS); (2) receive Sexual 

Orientation and Gender Identity (SOGI) 

and Birth Sex data elements (with 

United States Core Data for 

Interoperability (USCDI) value sets) for 

sexually transmitted diseases (STD) and 

Hepatitis; (3) receive an extension of 

three years to continue to receive the 

current SOGI data elements for STD; 

and (4) receive new disease-specific 

data elements for AGS, COVID–19, 

Cryptosporidiosis, Cyclosporiasis, 

Hepatitis, and STD (not congenital). 

The NNDSS currently facilitates the 

submission and aggregation of case 

notification data voluntarily submitted 

to CDC from 60 jurisdictions: Public 

health departments in every U.S. state, 

New York City, Washington DC, five 

U.S. territories (American Samoa, the 

Commonwealth of Northern Mariana 

Islands, Guam, Puerto Rico, and the U.S. 

Virgin Islands), and three freely 

associated states (Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau). This information is shared 

across jurisdictional boundaries and 

both surveillance and prevention and 

control activities are coordinated at 

regional and national levels. 

Over 90% of case notifications are 

encrypted and submitted to NNDSS 

electronically from already existing 

databases by automated electronic 

messages. When automated 

transmission is not possible, case 

notifications are faxed, emailed, or 

uploaded to a secure network or entered 

into a secure website. All case 

notifications that are faxed or emailed 

are done so in the form of an aggregate 

weekly or annual report, not individual 

cases. These different mechanisms used 

to send case notifications to CDC vary 

by the jurisdiction and the disease or 

condition. Jurisdictions remove most 

personally identifiable information (PII) 

before data are submitted to CDC, but 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law. All data are treated in a secure 

manner consistent with the technical, 

administrative, and operational controls 

required by the Federal Information 

Security Management Act of 2002 

(FISMA) and the 2010 National Institute 

of Standards and Technology (NIST) 

Recommended Security Controls for 

Federal Information Systems and 

Organizations. Weekly tables of 

nationally notifiable diseases are 

available through CDC WONDER and 

data.cdc.gov. Annual summaries of 

finalized nationally notifiable disease 

data are published on CDC WONDER 

and data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of message mapping guide (MMG) 

implementation, separate burden hours 

incurred for annual data reconciliation 

and submission, and separate one-time 

burden hours incurred for the addition 

of new diseases and data elements. The 

burden estimates for the one-time 

burden for reporting jurisdictions are for 

the addition of case notification data for 

AGS; and disease-specific data elements 

for AGS, COVID–19, Cryptosporidiosis, 

Cyclosporiasis, Hepatitis, and STD (not 

congenital). 

CDC requests OMB approval for an 

estimated 18,294 burden hours, a 

decrease from the previously approved 

18,954 due to fewer disease-specific 

data elements being added. There is no 

cost to respondents other than the time 

to participate. 


jspears on DSK121TN23PROD with NOTICES1
33486 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

States .............................................................. Weekly (Automated) ....................................... 50 52 20/60 

States .............................................................. Weekly (Non- automated) .............................. 10 52 2 

States .............................................................. Weekly (MMG Implementation) ..................... 50 52 4 

States .............................................................. Annual ............................................................ 50 1 75 

States .............................................................. One-time Addition of Diseases and Data Elements.50 1 1 

Territories ........................................................ Weekly (Automated) ....................................... 5 52 20/60 

Territories ........................................................ Weekly, Quarterly Non-automated) ............... 5 56 20/60 

Territories ........................................................ Weekly (MMG Implementation) ..................... 5 52 4 

Territories ........................................................ Annual ............................................................ 5 1 5 

Territories ........................................................ One-time Addition of Diseases and Data Elements.5 1 1 

Freely Associated States ................................ Weekly (Automated) ....................................... 3 52 20/60 

Freely Associated States ................................ Weekly, Quarterly (Non-automated) .............. 3 56 20/60 

Freely Associated States ................................ Annual ............................................................ 3 1 1

Freely Associated States ................................ One-time Addition of Diseases and Data Elements.3 1 12 

Cities ............................................................... Weekly (Automated) ....................................... 2 52 20/60 

Cities ............................................................... Weekly (Non-automated) ............................... 2 52 2 

Cities ............................................................... Weekly (MMG Implementation) ..................... 2 52 4 

Cities ............................................................... Annual ............................................................ 2 1 75 

Cities ............................................................... One-time Addition of Diseases and Data Elements.2 1 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–11769 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment (CHACHSPT) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

CDC/HRSA Advisory Committee on 

HIV, Viral Hepatitis and STD Prevention 

and Treatment (CHACHSPT). The 

CHACHSPT consists of 18 experts in 

fields associated with public health; 

epidemiology; laboratory practice; 

immunology; infectious diseases; drug 

abuse; behavioral science; health 

education; healthcare delivery; state 

health programs; clinical care; 

preventive health; medical education; 

health services and clinical research; 

and healthcare financing, who are 

selected by the Secretary of the U.S. 

Department of Health and Human 

Services (HHS). 

DATES: Nominations for membership on 

the CHACHSPT must be received no 

later than October 1, 2022. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

electronically mailed to nchhstppolicy@

cdc.gov with the subject line of ‘‘CHAC 

2023 Nomination.’’ 

FOR FURTHER INFORMATION CONTACT: 

Marah Condit, MS, Committee 

Management Lead, National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention, CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, Georgia 

30329–4027; Telephone: (404) 639– 

3423; Email: MCondit@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

Secretary of HHS, and by delegation, the 

CDC Director and the Administrator, 

Health Resources and Services 

Administration (HRSA), are authorized 

by the Public Health Service Act to: (1) 

Conduct, encourage, cooperate with, 

and assist other appropriate public 

health authorities, scientific 

institutions, and scientists in the 

conduct of research, investigations, 

experiments, demonstrations, and 

studies related to the cases, diagnosis, 

treatment, control, and prevention of 

physical and mental diseases, and other 

impairments; (2) assist states and their 

political subdivisions in preventing, 

suppressing, and treating communicable 

diseases and other preventable 

conditions and in promoting health and 

well-being; (3) assist public and 

nonprofit private entities in preventing, 

controlling, and treating sexually 

transmitted diseases (STDs), including 

the human immunodeficiency virus 

(HIV); (4) improve health and achieve 

health equity through access to quality 

services and a skilled health workforce 

and innovative programs; (5) support 

healthcare services to persons living 

with or at risk for HIV, viral hepatitis, 

and other STDs; and (6) advance the 

education of health professionals and 

the public from HIV, viral hepatitis, and 

other STDs. 

CHACHSPT meets at least two times 

each calendar year, or at the discretion 

of the Designated Federal Officers in 

consultation with the CHACHSPT cochairs. 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. The 

CHACHSPT charter stipulates that the 

Committee shall include representation 

of persons with HIV and other affected 

populations; state and local health and 

education agencies; HIV/viral hepatitis/ 


jspears on DSK121TN23PROD with NOTICES1